Clario Partners with AWS to Enhance Clinical Data Analysis with AI

Clario has announced a multi-year collaboration with Amazon Web Services (AWS) to enhance its generative AI platform, as stated in a press release. This partnership aims to improve the processing of complex clinical documents and trial data, thereby reducing clinical trial startup times.

By leveraging AWS's AI and machine learning technologies, Clario's platform will enable healthcare and life sciences organizations to process data with greater speed and accuracy. This collaboration is expected to streamline operations and deliver regulatory-grade data more efficiently, ultimately improving patient outcomes.

Clario's generative AI platform orchestrates multiple large language models and deep learning models using AWS infrastructure. This scalable system transforms vast volumes of unstructured information into actionable insights, empowering life sciences companies to accelerate innovation in drug development.